Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Altimmune Inc
Science
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Novo Nordisk A/S
Walt Disney Co
Investing
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Europe: Top News And Analysis
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Business News
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Europe Markets
Pharmaceuticals
Europe News
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Biotech and Pharmaceuticals
Labor economy
Social issues
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
World Markets
Europe Markets
World Economy
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Eli Lilly and Co
Obesity
Small business
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
U/S/ Markets
Apple Inc
Stock markets
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Markets
Amgen Inc
stocks
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Technology
Health care industry
Internet
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Uber Technologies Inc
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
AstraZeneca PLC
Europe Markets
Health care industry
From
CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags
Enterprise
Business News
Novo Nordisk A/S
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Health & Science
Pharmaceuticals
Roche Holding AG
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Social issues
US: News
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Amgen Inc
Structure Therapeutics Inc
AstraZeneca PLC
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Eli Lilly and Co
US: News
Novo Nordisk A/S
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
May 02, 2024
Tags
Novo Nordisk A/S
Pharmaceuticals
Earnings
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Novo Nordisk A/S
US: News
Social issues
From
CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
April 24, 2024
Tags
Politics
Congress
Health & Science
From
CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
Tags
Health & Science
Pharmaceuticals
Business
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Simply Good Foods Co
Vital Farms Inc
Packaged Food and Meats
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Companies
Breaking news
Health care industry
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.